Retatrutide vs Mounjaro: How the Triple Agonist Compares to Tirzepatide
The short version: Retatrutide and Mounjaro (tirzepatide) are both incretin-based peptides, but they work differently. Mounjaro is a dual agonist that activates GIP and GLP-1 receptors and is licensed for type 2 diabetes and weight management in the UK. Retatrutide is a triple agonist that also activates the glucagon receptor and has not been approved […]
Retatrutide vs Mounjaro: How the Triple Agonist Compares to Tirzepatide Read Post »





